GlobeNewswire Inc.··NaGenmab Corrects Executive Share Transaction, Reveals DKK 1,867.50 Pricing
Genmab corrects insider transaction report, fixing share price from DKK 0.00 to DKK 1,867.50 for executive RSU settlement.
GMABrestricted stock unitsexecutive compensation